Imflamol SR Uses

Did you have any side effects with this medicine?
sponsored

What is Imflamol SR?

Imflamol SR is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and other symptoms of arthritis of the joints (eg, osteoarthritis), such as inflammation, swelling, stiffness, and joint pain. However, Imflamol SR does not cure osteoarthritis and will help you only as long as you continue to use it.

Imflamol SR topical 3% gel is also used to treat actinic keratosis, a skin problem that may become cancerous if not treated. The exact way that topical Imflamol SR helps this condition is unknown.

Imflamol SR topical solution is used to treat pain and swelling caused by osteoarthritis of the knees.

Imflamol SR topical patch is used to treat acute pain caused by minor strains, sprains, and contusions (bruises).

Imflamol SR is available only with your doctor's prescription.

Imflamol SR indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Intramuscular

Renal colic

Adult: As Imflamol SR Na: 75 mg, may repeat once after 30 min if needed. Max: 150 mg/day. Max period: 2 days.

Intramuscular

Bursitis, Pain and inflammation associated with musculoskeletal and joint disorders, Rheumatoid arthritis, Sprains, Strains, Tendinitis, Acute gout, Dysmenorrhoea

Adult: As Imflamol SR Na: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions. Max period: 2 days.

Intravenous

Postoperative pain

Adult: As Imflamol SR Na: 75 mg infusion in glucose 5% or NaCl 0.9% (previously buffered w/ Na bicarbonate) given over 30-120 min or as bolus inj, may repeat after 4-6 hr if necessary. Max period: 2 days.

Intravenous

Prophylaxis of postoperative pain

Adult: As Imflamol SR Na: Initially, 25-50 mg infusion given after surgery over 15-60 min followed by 5 mg/hr. Alternatively, initial dose may be given as bolus inj over 5-60 sec followed by additional inj, may repeat after 4-6 hr if necessary. Max: 150 mg/day. Max period: 2 days.

Ophthalmic

Postoperative ocular inflammation

Adult: As Imflamol SR Na (0.1% soln): Instill into the appropriate eye 4 times daily starting 24 hr after surgery for up to 28 days.

Ophthalmic

Inflammation and discomfort after strabismus surgery

Adult: As Imflamol SR Na (0.1% soln): Instill 1 drop 4 times daily for the 1st wk; then tid in the 2nd wk, bid in the 3rd wk, and as required for the 4th wk.

Ophthalmic

Pain and discomfort after radial keratotomy

Adult: As Imflamol SR Na (0.1% soln): Instill 1 drop before surgery followed by 1 drop immediately after surgery, and then 1 drop 4 times daily for up to 2 days.

Ophthalmic

Pain after accidental trauma

Adult: As Imflamol SR Na (0.1% soln): Instill 1 drop 4 times daily for up to 2 days.

Ophthalmic

Control of inflammation after argon laser trabeculoplasty

Adult: As Imflamol SR Na (0.1% soln): Instill 1 drop 4 times during the 2 hr before procedure followed by 1 drop 4 times daily, up to 7 days after procedure.

Ophthalmic

Prophylaxis of intra-operative miosis

Adult: As Imflamol SR Na (0.1% soln): Instill into appropriate eye 4 times w/in 2 hr before surgery.

Ophthalmic

Post-photorefractive keratectomy pain

Adult: As Imflamol SR Na (0.1% soln): Instill into the affected eye twice, an hr before surgery, then 1 drop twice at 5-min intervals immediately after surgery, then every 2-5 hr while awake for up to 24 hr.

Ophthalmic

Seasonal allergic conjunctivitis

Adult: As Imflamol SR Na (0.1% soln): Instill 1 drop before surgery followed by 1 drop immediately after surgery, and then 1 drop 4 times daily for up to 2 days.

Oral

Bursitis, Pain and inflammation associated with musculoskeletal and joint disorders, Rheumatoid arthritis, Sprains, Strains, Tendinitis, Acute gout, Dysmenorrhoea

Adult: As Imflamol SR Na: 75-150 mg/day in divided doses. Max: 150 mg/day.

Oral

Migraine

Adult: As Imflamol SR K: Initially, 50 mg taken at the 1st sign of an attack, an additional dose of 50 mg may be taken after 2 hr if symptoms persist. If needed, further doses of 50 mg may be taken 4-6 hrly. Max: 200 mg/day.

Rectal

Acute gout, Bursitis, Dysmenorrhoea, Pain and inflammation associated with musculoskeletal and joint disorders, Rheumatoid arthritis, Sprains, Strains, Tendinitis

Adult: As Imflamol SR Na: 100 mg once daily.

Topical/Cutaneous

Actinic keratoses

Adult: As Imflamol SR Na (3% gel): Apply bid for 60-90 days.

Topical/Cutaneous

Osteoarthritis

Adult: As Imflamol SR Na (1.6% soln): Apply in small amounts (20 or 40 drops) onto affected area 4 times daily. As Na: (1% gel): Apply to the affected area 4 times daily. Max: 32 g/day over the affected area.

Topical/Cutaneous

Local symptomatic relief of pain and inflammation

Adult: As Imflamol SR Na (1% gel): Apply onto affected area 3 or 4 times daily.

Transdermal

Acute pain

Adult: Sprains, strains, contusions: 1 patch bid.

How should I use Imflamol SR?

Use Imflamol SR solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Imflamol SR solution.

Uses of Imflamol SR in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored

Imflamol SR is used to relieve pain from various conditions. This form of Imflamol SR is used to treat migraine headaches. Imflamol SR is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever.

OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.

This medication may also be used to treat gout attacks.

How to use Imflamol SR

Read the Medication Guide provided by your pharmacist before you start taking Imflamol SR and each time you get a refill. If you have any questions, ask your doctor or pharmacist.

Take this medication by mouth as directed by your doctor. Empty the contents of one packet into a cup containing 1 to 2 ounces (30 to 60 milliliters) of water. Mix well and drink all of it right away. Do not mix with any liquid other than water. If stomach upset occurs while taking this medication, take it with food, milk, or an antacid. However, if you take this medication with a meal high in fat, it may not work as well.

There are different brands and forms of this medication available. Because different forms do not have the same effects at equal strengths, do not switch forms of Imflamol SR unless your doctor tells you to.

To reduce your risk of stomach bleeding and other side effects, take this medication at the lowest effective dose. Do not increase your dose or take it more often than prescribed.

Pain medications work best if they are used as the first signs of pain occur. If you wait until the pain has worsened, the medication may not work as well.

Tell your doctor if your condition persists or worsens.

Imflamol SR description

sponsored

The active substance is sodium-[o[(2,6-dichlorophenyl)-amino]-phenyl]-acetate (= Imflamol SR sodium).

Each enteric tablet contains 25 mg or 50 mg of Imflamol SR sodium.

One prolonged-release tablet contains 100 mg of Imflamol SR sodium.

Excipients/Inactive Ingredients: Gastro-Resistant Tablet: Core for 25 mg and 50 mg: Cellulose microcrystalline; lactose monohydrate; magnesium stearate; maize starch; povidone; silica, colloidal anhydrous; sodium starch glycolate (type A).

Coating for 25 mg and 50 mg: Hypromellose; iron oxide yellow (E172); macrogoglycerol hydroxystearate; methacrylic acid-ethyl acrylate copolymer; macrogol 8000; talc; titanium dioxide (E171); simeticone; alpha-octadecyl-omega-hydroxy-polyglykolether; sorbic acid.

Coating for 50 mg: Iron oxide red (E172).

SR Tablet: Tablet Core: Cetyl alcohol; magnesium stearate; povidone; silica; colloidal anhydrous; sucrose.

Tablet Coating: Hypromellose; iron oxide red (E172); macrogol 8000; polysorbate 80; sucrose; talc; titanium dioxide (E171). Printing Ink: Carbon black, shellac, ammonium hydroxide, simethicone.

Injection: Each ampoule also contains the following excipients: Mannitol, sodium metabisulfite (E223), benzyl alcohol, propylene glycol, water for injection, sodium hydroxide.

Imflamol SR dosage

sponsored

Imflamol SR Dosage

Generic name: Imflamol SR 18mg

Dosage form: capsule

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

General Dosing Instructions

Carefully consider the potential benefits and risks of Imflamol SR and other treatment options before deciding to use Imflamol SR. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.

The effectiveness of Imflamol SR when taken with food has not been studied in clinical studies. Taking Imflamol SR with food may cause a reduction in effectiveness compared to taking Imflamol SR on an empty stomach.

Acute Pain

For management of mild to moderate acute pain, the dosage is 18 mg or 35 mg orally three times daily.

Osteoarthritis Pain

For management of osteoarthritis pain, the dosage is 35 mg orally three times daily.

Dosage Adjustments in Patients with Hepatic Impairment

Patients with hepatic disease may require reduced doses of Imflamol SR compared to patients with normal hepatic function. As with other Imflamol SR products, start treatment at the lowest dose. If efficacy is not achieved with the lowest dose, discontinue use.

Non-Interchangeability with Other Formulations of Imflamol SR

Imflamol SR capsules are not interchangeable with other formulations of oral Imflamol SR even if the milligram strength is the same. Imflamol SR capsules contain Imflamol SR free acid whereas other Imflamol SR products contain a salt of Imflamol SR, i.e., Imflamol SR potassium or sodium. A 35 mg dose of Imflamol SR is approximately equal to 37.6 mg of sodium Imflamol SR or 39.5 mg of potassium Imflamol SR. Therefore, do not substitute similar dosing strengths of other Imflamol SR products without taking this into consideration.

More about Imflamol SR (Imflamol SR)

Consumer resources

Professional resources

Related treatment guides

Imflamol SR interactions

See also:
What other drugs will affect Imflamol SR?

Aspirin: Concomitant administration of Imflamol SR and aspirin is not recommended because Imflamol SR is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels and AUC values.

Anticoagulants: While studies have not shown Imflamol SR to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs. Because prostaglandins play an important role in hemostasis and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including Imflamol SR and warfarin, requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.

Digoxin, Methotrexate, Cyclosporine: Imflamol SR, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs. Ingestion of Imflamol SR may increase serum concentrations of digoxin and methotrexate and increase cyclosporine's nephrotoxicity. Patients who begin taking Imflamol SR or who increase their Imflamol SR dose or any other NSAID while taking digoxin, methotrexate or cyclosporine may develop toxicity characteristics for these drugs. They should be observed closely, particularly if renal function is impaired. In the case of digoxin, serum levels should be monitored.

Lithium: Imflamol SR decreases lithium renal clearance and increases lithium plasma levels. In patients taking Imflamol SR and lithium concomitantly, lithium toxicity may develop.

Oral Hypoglycemics:

Imflamol SR does not alter glucose metabolism in normal subjects nor does it alter the effects of oral hypoglycemic agents. There are rare reports, however, from marketing experiences, of changes in effects of insulin or oral hypoglycemic agents in the presence of Imflamol SR that necessitated changes in the doses of such agents. Both hypo- and hyperglycemic effects have been reported. A direct causal relationship has not been established, but physicians should consider the possibility that Imflamol SR may alter a diabetic patient's response to insulin or oral hypoglycemic agents.

Diuretics: Imflamol SR and other NSAIDs can inhibit the activity of diuretics. Concomitant treatment with potassium-sparing diuretics may be associated with increased serum potassium levels.

Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline or digitoxin did not significantly affect the peak levels and AUC values of Imflamol SR. Phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of Imflamol SR therapy.

Imflamol SR side effects

See also:
What are the possible side effects of Imflamol SR?

Fluid Retention and Edema: Fluid retention and edema have been observed in some patients taking Imflamol SR. Therefore, as with other NSAIDs, Imflamol SR should be used with caution in patients with history of cardiac decompensation, hypertension or other conditions predisposing to fluid retention.

Hematological Effects: Anemia is sometimes seen in patients receiving Imflamol SR or other NSAIDs. This may be due to fluid retention, GI blood loss or an incompletely described effect upon erythropoiesis.

Renal Effects: As a class, NSAIDs have been associated with renal papillary necrosis and other abnormal renal pathology in long-term administration to animals. In patients treated with Imflamol SR, rare cases of interstitial nephritis and papillary necrosis have been reported. A second form of renal toxicity, generally associated with NSAIDs, is seen in patients with conditions leading to a reduction in renal blood flow or blood volume, where renal prostaglandins have a supported role in the maintenance of renal perfusion. In these patients, administration of an NSAID results in a dose-dependent decrease in prostaglandin synthesis and secondarily, in a reduction of renal blood flow, which may precipitate over the renal failure. Patients at greater risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and the elderly.

Porphyria: The use of Imflamol SR in patients with hepatic porphyria should be avoided.

Aseptic Meningitis: As with other NSAIDs, aseptic meningitis with fever and coma has been observed in rare occasions in patients on Imflamol SR therapy. Although it is probably more likely to occur in patients with systemic lupus erythematosus and related connective tissue diseases, it has been reported in patients who do not have an underlying chronic disease. If signs or symptoms of meningitis develop in a patient on Imflamol SR, the possibility of it being related to Imflamol SR should be considered.

There may be pain and occasionally tissue damage at the site of injection when given IM.

Imflamol SR contraindications

See also:
What is the most important information I should know about Imflamol SR?

Hypersensitivity to Imflamol SR sodium or to any of the excipients of Imflamol SR.

Active gastric or intestinal ulcer, bleeding or perforation.

Last trimester of pregnancy.

Hepatic, renal and severe cardiac failure.

Patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by acetylsalicylic acid and/or other drugs with prostaglandin-synthetase inhibitory activity.

Treatment of peri-operative pain in setting of coronary artery bypass graft (CABG) surgery.

The use of high dose Imflamol SR (150 mg/day) for >4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension.

Established Cardiovascular Disease or Significant Cardiovascular Risk Factors: The use of high dose Imflamol SR (150mg/day) for >4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension. If Imflamol SR treatment is needed, patients with established cardiovascular disease, uncontrolled hypertension or significant cardiovascular risk factors (eg, hypertension, hyperlipidaemia, diabetes mellitus and smoking) should be treated only after careful consideration and at doses ≤100 mg daily if the treatment is for >4 weeks. As the cardiovascular risks of Imflamol SR may increase with dose and duration of exposure, Imflamol SR should always be prescribed at the lowest effective daily dose and for the shortest duration possible.

Renal Impairment: Imflamol SR is contraindicated in patients with renal failure. No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering Imflamol SR to patients with mild to moderate renal impairment.

Hepatic Impairment: Imflamol SR is contraindicated in patients with hepatic failure. No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering Imflamol SR to patients with mild to moderate hepatic impairment.



Active ingredient matches for Imflamol SR:

Diclofenac


Unit description / dosage (Manufacturer)Price, USD
Imflamol SR 100 mg Tablet$ 0.02

List of Imflamol SR substitutes (brand and generic names):

Gel; Topical; Diclofenac Sodium 1%
INAC Capsule/ Tablet / 50mg / 10 units (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.17
INAC Injection / 75mg / 3ml units (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.07
INAC Capsule/ Tablet / 100mg / 10 units (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.34
Inac 50 mg x 1000's (Zydus Alidac (Zydus Cadila Healthcare Ltd))
Inac 46.5mg DT-TAB / 100 (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 1.39
Inac 50mg TAB / 10 (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.21
Inac 100mg TR-TAB / 10 (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.42
Inac 75mg/3ml AMP / 3ml (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.13
Gel; Topical; Diclofenac Diethylamine 1% (Zydus Alidac (Zydus Cadila Healthcare Ltd))
Injectable; Injection; Diclofenac Sodium 25 mg / ml (Zydus Alidac (Zydus Cadila Healthcare Ltd))
Tablets, Dispersible; Oral; Diclofenac Sodium 46.5 mg (Zydus Alidac (Zydus Cadila Healthcare Ltd))
Tablets, Enteric Coated; Oral; Diclofenac Sodium 50 mg (Zydus Alidac (Zydus Cadila Healthcare Ltd))
Tablets; Oral; Diclofenac Sodium 50 mg (Zydus Alidac (Zydus Cadila Healthcare Ltd))
Tablets, Time Release; Oral; Diclofenac Sodium 100 mg (Zydus Alidac (Zydus Cadila Healthcare Ltd))
50 mg x 10's (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.21
100 mg x 10's (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.42
75 mg x 3 mL x 3ml (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.13
46.5 mg x 100's (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 1.39
Inac 75 mg Injection (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.04
Inac 50 mg Tablet (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.02
INAC 25 MG INJECTION 1 vial / 3 ML injection each (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.08
INAC 50 MG TABLET 1 strip / 4 tablets each (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.28
INAC 50 MG TABLET 1 strip / 10 tablets each (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.29
INAC 75 MG INJECTION 1 vial / 3 ML injection each (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.08
INAC 75 MG INJECTION 1 vial / 2 ML injection each (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.17
INAC GEL 1 tube / 20 GM gel each (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.58
INAC enteric-coated tab 50 mg x 10's (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.27
INAC TR tab 100 mg x 10's (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.42
INAC inj 75 mg x 3 mL x 3ml (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.13
INAC dispertab 46.5 mg x 10's (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.14
Inac enteric-coated tab 50 mg 1000's (Zydus Alidac (Zydus Cadila Healthcare Ltd))
Inac 25mg Injection (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.03
Inac 50mg Tablet (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.03
Inac 75mg Injection (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.03
Inac 1% w/w Gel (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.58
Inac Gel 1%w/w GEL / 20g (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.47
1 % w/w x 20g (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.47
Inac Gel 20 gm Gel (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.46
INAC GEL topical gel 1 % w/w x 20g (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.47
Inac TR 100 mg x 100's (Zydus Alidac (Zydus Cadila Healthcare Ltd))
Inac TR 100 mg Tablet (Zydus Alidac (Zydus Cadila Healthcare Ltd))$ 0.04
Inac TR pellets cap 100 mg 100's (Zydus Alidac (Zydus Cadila Healthcare Ltd))
INDIAFLAM MD TABLET 1 strip / 10 tablet mds each (Votary Laboratories I Ltd)$ 0.26
Indofen E Eye 5 ml Drop (Adley Formulation)$ 0.05
Indofen-E 0.1% w/v EYE-DPS / 5ml (Adley)$ 0.25
0.1 % w/v x 5ml (Adley)$ 0.25
INDOFEN-E eye drops 0.1 % w/v x 5ml (Adley)$ 0.25
Indofen-SR 100mg TAB / 10 (Adley)
100 mg x 10's (Adley)
INDOFEN-SR tab 100 mg x 10's (Adley)
INFADIC inj 75 mg x 1 mL x 5ml (Agron Rem.)

References

  1. DailyMed. "DICLOFENAC EPOLAMINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "diclofenac". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "diclofenac". http://www.drugbank.ca/drugs/DB00586 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Imflamol SR are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Imflamol SR. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


1 consumer reported age

Users%
46-601
100.0%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 1 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved